CCRM
Louis Rogers PhD PMP DTM is an accomplished Project Manager specializing in manufacturing excellence and GMP manufacturing for cell and gene therapy, with extensive experience in leading clinical trials and managing contracts and budgets within the pharmaceutical industry. Currently serving as Project Manager for Manufacturing Excellence Projects at CCRM since September 2021, Louis collaborates with stakeholders to implement lean six sigma principles and change management practices. Previous roles include Local Study Lead at Bayer Pharmaceuticals, where project management for research studies took place, and Senior Contracts and Budgets Specialist, focusing on negotiating agreements with clinical trial sites. Louis's diverse background encompasses project management at various organizations including PRA Health Sciences, Everest Clinical Research Services Inc., and Patheon Inc., supported by a robust academic foundation including a PhD from the University of St Andrews and professional development in project management methodologies.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.